KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adaptive Biotechnologies (ADPT) Other Non-Current Liabilities (2019 - 2025)

Historic Other Non-Current Liabilities for Adaptive Biotechnologies (ADPT) over the last 6 years, with Q3 2025 value amounting to $20000.0.

  • Adaptive Biotechnologies' Other Non-Current Liabilities changed 0.0% to $20000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $20000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $20000.0 for FY2024, which is N/A changed from last year.
  • Per Adaptive Biotechnologies' latest filing, its Other Non-Current Liabilities stood at $20000.0 for Q3 2025, which was down 0.0% from $20000.0 recorded in Q2 2025.
  • In the past 5 years, Adaptive Biotechnologies' Other Non-Current Liabilities ranged from a high of $128.2 million in Q2 2023 and a low of $20000.0 during Q2 2024
  • For the 4-year period, Adaptive Biotechnologies' Other Non-Current Liabilities averaged around $50.5 million, with its median value being $20000.0 (2024).
  • In the last 5 years, Adaptive Biotechnologies' Other Non-Current Liabilities plummeted by 9998.44% in 2024 and then changed by 0.0% in 2025.
  • Quarter analysis of 4 years shows Adaptive Biotechnologies' Other Non-Current Liabilities stood at $125.4 million in 2022, then grew by 2.24% to $128.2 million in 2023, then plummeted by 99.98% to $20000.0 in 2024, then changed by 0.0% to $20000.0 in 2025.
  • Its Other Non-Current Liabilities stands at $20000.0 for Q3 2025, versus $20000.0 for Q2 2025 and $20000.0 for Q1 2025.